Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2018-05-09 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Insider's tradings
Director's Dealing Classification · 100% confidence The document is a formal notification regarding transactions in Coloplast shares by a member of the executive management (Kristian Villumsen). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) regarding the reporting of transactions by persons discharging managerial responsibilities. This fits the definition of a Director's Dealing (DIRS) report.
2018-05-09 Danish
Insider's tradings
Director's Dealing Classification · 100% confidence The document is a notification of transactions in Coloplast shares by a member of the executive management (Kristian Villumsen). It explicitly mentions 'Indberetning af ledende medarbejderes og disses nærtståendes transaktioner' (Reporting of transactions by persons discharging managerial responsibilities and their closely associated persons) under the Market Abuse Regulation (MAR). This is a classic Director's Dealing disclosure.
2018-05-09 Danish
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document explicitly details transactions executed under a 'Share buy-back programme' for the period of April 30 to May 4, 2018. This involves the company purchasing its own shares. According to the definitions, the category 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it is a report of transactions, it is not a general regulatory filing (RNS) or a capital change announcement (SHA), but specifically addresses share repurchases, making POS the most precise fit.
2018-05-07 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document is titled "Aktietilbagekøb uge 18/2018" (Share Buyback week 18/2018) and details the transactions made under the company's share buyback program for a specific period (April 30 - May 4, 2018). It reports the number of shares bought, the price, and the total amount spent, concluding with the current holding of treasury shares. This activity directly relates to the company managing its own stock, which corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory announcement, the specific nature of the content points more precisely to POS than the general 'RNS' fallback.
2018-05-07 Danish
Share buy-back week 18/2018
Transaction in Own Shares Classification · 100% confidence The document contains detailed transactional data related to Coloplast's share repurchase program for a specific week in May 2018. It includes dates, number of shares repurchased, prices, total amounts, and detailed trade execution information. The content is focused on the company's buyback of its own shares, with no indication of financial results, management commentary, or other report types. The presence of detailed transaction tables and references to regulatory standards for share buybacks confirms this is a report on share repurchase activity. Therefore, the document fits the category of Transaction in Own Shares (POS). The document length (15,000 characters) and detailed data confirm it is the report itself, not just an announcement or certification.
2018-05-07 English
Share buy-back week 18/2018
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from Coloplast detailing specific transactions made under a share buyback program (aktietilbagekøbsprogram). It lists the dates, number of shares purchased, prices, and the total accumulated amount, which is a standard disclosure for a company buying back its own shares. This fits the definition of 'Transaction in Own Shares' (POS).
2018-05-07 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.